Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design.
Volgraf, M., Sellers, B.D., Jiang, Y., Wu, G., Ly, C.Q., Villemure, E., Pastor, R.M., Yuen, P.W., Lu, A., Luo, X., Liu, M., Zhang, S., Sun, L., Fu, Y., Lupardus, P.J., Wallweber, H.J., Liederer, B.M., Deshmukh, G., Plise, E., Tay, S., Reynen, P., Herrington, J., Gustafson, A., Liu, Y., Dirksen, A., Dietz, M.G., Liu, Y., Wang, T.M., Hanson, J.E., Hackos, D., Scearce-Levie, K., Schwarz, J.B.
J. Med. Chem.
